How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Robotic Surgical Instruments Market
- By Product Type: Robotic Surgical Arms, Robotic Surgical End Effectors, Robotic Surgical Cameras, Robotic Surgical Control Systems, Robotic Surgical Energy Devices
- By Surgical Application: Orthopedic Surgery, Cardiovascular Surgery, General Surgery, Urological Surgery, Gynecological Surgery, Neurosurgery
- By Technology: Telerobotic Systems, Automated Robotic Systems, Semi-Autonomous Robotic Systems
- By End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics
- By Component Type: Robotic Manipulators, Surgical Instruments, Imaging Systems, Control Units
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Robotic Surgical Arms leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 17 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 301 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.179 →
- 12 Company Profiles 17 players: SWOT & benchmarking p.187 →
Full report · locked preview
Everything inside the Robotic Surgical Instruments Market report
A complete, evidence-based study - 12 chapters and 126 sections covering market size, segmentation across 5 axes, regional analysis and 17 company profiles, forecast to 2033.
Segmentation covered
Product Type 5
Surgical Application 6
Technology 3
End User 3
Component Type 4
Companies profiled
Intuitive Surgical Inc.
Medtronic plc
Stryker Corporation
Zimmer Biomet Holdings Inc.
Smith & Nephew plc
TransEnterix
Inc. (Asensus Surgical)
Verb Surgical Inc. (a collaboration between Verily and Johnson & Johnson)
Globus Medical Inc.
Renishaw plc
Titan Medical Inc.
CMR Surgical Ltd.
+5 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
17 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Intuitive Surgical Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Medtronic plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Stryker Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Zimmer Biomet Holdings Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Smith & Nephew plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →TransEnterix
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Inc. (Asensus Surgical)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Verb Surgical Inc. (a collaboration between Verily and Johnson & Johnson)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Globus Medical Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Renishaw plc
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Titan Medical Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →CMR Surgical Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Hansen Medical Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.227 →Avatera Medical GmbH
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Mazor Robotics Ltd. (acquired by Medtronic)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Corindus Vascular Robotics
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Inc. (a Siemens Healthineers company)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.250 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$3,155M by 2033 · 8.8% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Robotic Surgical Arms54.9
- Robotic Surgical End Effectors9.5
- Robotic Surgical Cameras6.7
- Robotic Surgical Control Systems11.9
- Robotic Surgical Energy Devices17.0
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$529.3M → $1,090M · 9.5%
Europe$368.9M → $717.4M · 8.7%
Asia Pacific$336.8M → $689.2M · 9.4%
Latin America$208.5M → $456.2M · 10.3%
Middle East and Africa$160.4M → $303.4M · 8.3%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →8.772026
8.802027
8.802028
8.812029
8.832030
8.832031
8.842032
8.862033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Intuitive Surgical Inc.23.6
- Medtronic plc18.6
- Stryker Corporation13.5
- Zimmer Biomet Holdings Inc.4.9
- Smith & Nephew plc5.7
- TransEnterix5.7
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type16.4%
Surgical Application27.3%
Technology11.2%
End User23.7%
Component Type21.4%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.5
- Europe22.0
- Asia Pacific21.2
- Latin America14.0
- Middle East and Africa9.3
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Intuitive Surgical Inc. | 92 | 75 | 81 | 88 | 84 | 95 | 86 |
| Medtronic plc | 74 | 79 | 72 | 72 | 74 | 88 | 77 |
| Stryker Corporation | 86 | 81 | 65 | 65 | 75 | 63 | 73 |
| Zimmer Biomet Holdings Inc. | 64 | 79 | 72 | 73 | 58 | 79 | 71 |
| Smith & Nephew plc | 56 | 51 | 52 | 76 | 76 | 63 | 62 |
| TransEnterix | 57 | 66 | 51 | 55 | 46 | 55 | 55 |
| Inc. (Asensus Surgical) | 47 | 48 | 48 | 50 | 56 | 48 | 50 |
| Verb Surgical Inc. (a collaboration between Verily and Johnson & Johnson) | 53 | 41 | 51 | 35 | 48 | 35 | 44 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Intuitive Surgical Inc.
- Medtronic plc
- Stryker Corporation
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc. | ✓ | ✓ | ◐ | ◐ | ✓ | ✓ |
| Medtronic plc | ◐ | ◐ | ✓ | ◐ | ◐ | ✓ |
| Stryker Corporation | ✓ | ◐ | ✓ | ✓ | ◐ | − |
| Zimmer Biomet Holdings Inc. | ◐ | ✓ | ◐ | − | − | ✓ |
| Smith & Nephew plc | − | − | − | ◐ | ✓ | − |
| TransEnterix | − | − | − | − | − | − |
| Inc. (Asensus Surgical) | − | − | ◐ | − | − | − |
| Verb Surgical Inc. (a collaboration between Verily and Johnson & Johnson) | − | − | ◐ | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Intuitive Surgical Inc.86
2Medtronic plc77
3Stryker Corporation73
4Zimmer Biomet Holdings Inc.71
5Smith & Nephew plc62
6TransEnterix55
7Inc. (Asensus Surgical)50
8Verb Surgical Inc. (a collaboration between Verily and Johnson & Johnson)44
Competitive tiers
§8.4 · p.172 →Leader1
Set the pace on share, breadth and innovation.
Intuitive Surgical Inc.
Challenger3
Strong scale, closing on the leaders.
Medtronic plcStryker CorporationZimmer Biomet Holdings Inc.
Contender1
Focused players with pockets of strength.
Smith & Nephew plc
Niche3
Specialists in a single segment or region.
TransEnterixInc. (Asensus Surgical)Verb Surgical Inc. (a collaboration between Verily and Johnson & Johnson)
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across Robotic Surgical Instruments Market — a $566M beachhead inside a $8.29B market.
Beachhead (SOM)$566Mobtainable near-term
Serviceable (SAM)$3.02Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
Robotic Surgical Arms
Best fit — highest urgency & budget in Product Type.
Economic buyer80 fit
Robotic Surgical End Effectors
Strong fit — clear ROI and a fast path to value.
End user67 fit
Robotic Surgical Cameras
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Surgical Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Technology
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel30%
Digital / self-serve18%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Robotic Surgical Instruments Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified44%
Sales qualified25%
Evaluation13%
Closed-won7%
$11.6KCAC
$58KLTV
5.0:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Robotic Surgical Instruments Market is a high-growth opportunity — $1.36B by 2033, compounding at 11.2%.
TAM · 2025$580Mtoday
TAM · 2033$1.36Bforecast
CAGR11.2%2027–2033
Cumulative$8.30Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$1.36BTotal addressable market
SAM$547MServiceable available market
SOM$110MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →11.2% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
17+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$1.36BLarge & growingTAM by 2033 at 11.2% CAGR
$547MServiceable nowreachable with today’s model
$110MBeachhead winobtainable near-term share
17+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$1.06BBear7.3% CAGR
$1.36BBase11.2% CAGR
$1.74BBull14.8% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Surgical Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Robotic Surgical Instruments Market — a $5.73B market by 2033. Plan: grow share from 11.4% to 18.1%.
Market size · 2033$5.73Btotal addressable
Market CAGR7.7%2027–2033
Target share18.1%from 11.4% today
Revenue ambition$1.04Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 11.4% | 18.1% | On track |
| Revenue | $633M | $1.04B | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 37.5% | 40.0% | On track |
| Customer retention | 85.9% | 92.9% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Surgical Application capability
A defensible second engine — invest in Surgical Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Surgical Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $154M capacity & capability investment
- Greenlight bolt-on M&A in Surgical Application
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeAhead
- Execution & talentBehind
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Robotic Surgical Instruments Market conversation — a $6.95B market you can size, segment and defend in minutes.
Market size · 2033$6.95Btotal opportunity
Growth7.4%CAGR to 2033
Addressable buyers928+accounts in scope
Typical ROI7.1×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.1×return on cost, year one
< 3 mopayback period
$47K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
17+players profiled in this market
Coverage includes
Intuitive Surgical Inc.Medtronic plcStryker CorporationZimmer Biomet Holdings Inc.Smith & Nephew plcTransEnterixInc. (Asensus Surgical)Verb Surgical Inc. (a collaboration between Verily and Johnson & Johnson)+9 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Robotic Surgical Instruments Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Robotic Surgical Instruments Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Robotic Surgery Systemsfor Endometrial Cancer Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportRobotic Surgery Simulator Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportRobotic Surgery Service Market
Robotic Surgery Service Market is valued at USD 6.5 Billion in 2025 and is expected to reach US…
$6.5B market · 2025 base year
View reportRobotic Surgery for Endometrial Cancer Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportRobotic Surgery for Cervical Cancer Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportRobotic Surgery Consumables Market
Market size, share, segmentation and regional forecast.
$6.1B market · 2025 base year
View reportRobotic Surgery Assistance System Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportRobotics in Healthcare Market
Robotics in Healthcare Market is valued at USD 8.7 Billion in 2025 and is expected to reach USD…
$8.7B market · 2025 base year
View reportRobotics for Physical Therapy Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportRobotic Scope Holder Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportRobotics Assisted Telesurgery Market
Market size, share, segmentation and regional forecast.
$560M market · 2025 base year
View reportRobotic Radiosurgery System Market
Market size, share, segmentation and regional forecast.
$4.0B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.